David Gerring
Corporate Officer/Principal presso ARECOR THERAPEUTICS PLC
Patrimonio netto: 264 284 $ in data 30/04/2024
Profilo
David Gerring has held positions as Vice President of Development at Arecor Ltd.
and Vice President of Business Development at Arecor Therapeutics Plc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
0.50% | 16/11/2022 | 154 626 ( 0.50% ) | 264 284 $ | 30/04/2024 |
Posizioni attive di David Gerring
| Società | Posizione | Inizio |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- David Gerring